Resources

Valsartan is significantly superior to amlodipine for prevention of new-onset type-2 diabetes in high-risk patients with hypertension.Tesaglitazar Shows Promise in

Type 2 patients who require insulin treatment, continuing metformin treatment reduced weight gain and insulin requirement, and improved glycemic control.

Simplicity of an oral insulin spray “will facilitate acceptance and increase use by primary care physicians and patients alike.

Than Glargine Reduction in A1c was significantly better in the premixed insulin aspart group then in the glargine group

Although we have a lot of information from ADA Evan David Rosen, M.D., Ph.D. Assistant Professor of Medicine, Harvard Medical School, brings us more research he uncovered about a new protein like drug from Lilly. FGF-21 is unique because as an anti-diabetic drug it appears to increase glucose uptake in …

The Importance of a Daily Multivitamin and Mineral Supplement For People with Diabetes and Prediabetes There were some interesting abstracts on the use of nutrients in diabetes and Melissa Diane Smith, Dpl Nutrition shares information about what to look for. By Melissa Diane Smith With all the single nutrient or …

A new study provides evidence that the pancreas continues to form beta cells even in the setting of long-standing type 1diabetes.

CVD Events Lowered by 60% Years Later for Intensive Group. By following the participants in the DCCT study since it’s conclusion in 1993, it has continued to provide new information. For the first time, intensive treatment of diabetic patients results in a significantly lower risk of heart disease by 57%.

Combination brings back normal blood glucose levels by increasing beta-cell mass.

A New, Long-Acting Insulin Treatment for Diabetes. Denmark’s Novo Nordisk said on Friday the United States Food and Drug Administration (FDA) has approved its long-acting 24 hr. insulin for treatment of diabetes.